Edan Instruments, Inc. (SHE:300206)

Market Cap	6.98B -8.6%
Revenue (ttm)	2.09B +15.7%
Net Income	345.60M +83.2%
EPS	0.60 +83.1%
Shares Out	579.66M
PE Ratio	20.19
Forward PE	n/a
Dividend	0.31 (2.60%)
Ex-Dividend Date	Apr 30, 2026

Volume	4,143,901
Open	12.03
Previous Close	11.96
Day's Range	11.98 - 12.16
52-Week Range	11.01 - 16.80
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Edan Instruments

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, telemetry and IT products; and obstetrics, pelvic floor rehabilitation, and gynecology products. It also provides ultrasound systems that include cart-based ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,475
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300206

Financial Performance

In 2025, Edan Instruments's revenue was 2.00 billion, an increase of 8.97% compared to the previous year's 1.83 billion. Earnings were 305.64 million, an increase of 88.54%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 4, 2026

Data Sources Report a data error